2e:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0gcbsntq5_9qd.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/3o-s-fbpanizg.js","/_next/static/immutable/chunks/0-t9leoxnnuho.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2f:T6641,

FEATURE	DETAIL
Risk Factors	Hypertension, diabetes mellitus, atrial fibrillation, atherosclerosis of vertebrobasilar system, hypercoagulable states, advanced age, multiple sclerosis (young patients)
Etiology	Ischemic infarction of basilar artery or its paramedian/circumferential branches; less commonly hemorrhage, demyelination, or pontine tumor
Patient Presentation	Acute onset of cranial nerve deficits (CN V through VIII territory) combined with contralateral motor or sensory deficits ("crossed" findings); may present with vertigo, diplopia, facial weakness, dysarthria, or quadriplegia depending on extent
Classic Physical Exam	Crossed findings: ipsilateral cranial nerve palsy with contralateral hemiparesis or hemisensory loss; conjugate gaze palsies; internuclear ophthalmoplegia; ipsilateral cerebellar ataxia in lateral lesions
Key Diagnostic Results	MRI with diffusion-weighted imaging (DWI) showing restricted diffusion in the pons; CT often negative for posterior fossa strokes; MRA or CTA demonstrating basilar artery stenosis or occlusion
Management	Acute ischemic stroke: IV alteplase within 4.5 hours of symptom onset; antiplatelet therapy for secondary prevention; endovascular thrombectomy for basilar artery occlusion in select cases; long-term risk factor control
Keywords	"Crossed findings," "locked-in," "one-and-a-half syndrome," "eyes look away from the lesion," "bilateral ventral pons," "AICA syndrome," "can only blink"

1. Pathophysiology

The pons is the middle segment of the brainstem, situated between the midbrain above and the medulla below. It is a densely packed relay station carrying ascending sensory pathways, descending motor tracts, and housing the nuclei of cranial nerves V (trigeminal), VI (abducens), VII (facial), and VIII (vestibulocochlear). Understanding pontine syndromes requires knowing what structures live medially versus laterally, because the blood supply is divided along that same axis.

The basilar artery runs along the ventral surface of the pons and gives off two sets of branches. The paramedian perforating branches supply the medial pons, which contains the corticospinal tract, the medial lemniscus (carrying proprioception and vibration), the CN VI nucleus, the CN VII fascicle (which wraps around the CN VI nucleus in the facial colliculus), the paramedian pontine reticular formation (PPRF) controlling ipsilateral horizontal conjugate gaze, and the medial longitudinal fasciculus (MLF) coordinating conjugate eye movements. The long circumferential branches and the anterior inferior cerebellar artery (AICA) supply the lateral pons, which contains the lateral spinothalamic tract (pain and temperature from the contralateral body), the CN V spinal nucleus and tract, the CN VII nucleus, the CN VIII nuclei, the middle cerebellar peduncle, and descending sympathetic fibers.

This anatomical split is why pontine strokes produce "crossed" deficits: a lesion in one side of the pons damages ipsilateral cranial nerve nuclei or fascicles (lower motor neuron pattern) while simultaneously disrupting contralateral long tracts (corticospinal, spinothalamic, or medial lemniscus) that have not yet decussated or have already crossed. This crossed pattern is the hallmark that localizes a lesion to the brainstem rather than to the cortex or spinal cord.

When the medial pons is infarcted, the corticospinal tract damage produces contralateral hemiparesis, and medial lemniscus damage causes contralateral loss of vibration and proprioception. The ipsilateral CN VI and CN VII fascicles are damaged, producing an ipsilateral lateral rectus palsy and an ipsilateral lower motor neuron facial palsy. The PPRF is destroyed, so the patient cannot direct both eyes toward the side of the lesion, creating an ipsilateral conjugate gaze palsy (the eyes "look away" from the lesion, which is the opposite pattern from a cortical stroke where eyes "look toward" the lesion).

When the lateral pons is infarcted (AICA territory), the middle cerebellar peduncle is damaged, causing ipsilateral cerebellar ataxia and intention tremor. CN VII and CN VIII nuclei involvement produces ipsilateral lower motor neuron facial palsy and ipsilateral sensorineural hearing loss with vertigo and nystagmus. The lateral spinothalamic tract damage causes contralateral pain and temperature loss in the body, while damage to the descending CN V spinal tract causes ipsilateral facial pain and temperature loss. Sympathetic fiber disruption results in ipsilateral Horner syndrome (miosis, ptosis, anhidrosis).

A bilateral ventral pontine infarct (from basilar artery occlusion) destroys both corticospinal tracts and corticobulbar fibers while sparing the dorsal reticular activating system. This produces the locked-in syndrome: the patient is fully conscious and cognitively intact but quadriplegic and unable to speak. The only preserved voluntary movements are vertical eye movements and blinking, because the supranuclear pathways controlling vertical gaze pass through the midbrain, not the pons. This is a critical exam concept: locked-in syndrome is not a disorder of consciousness; it is a motor output failure with preserved awareness.

2. Classification and Clinical Manifestation

SYNDROME	ARTERY	STRUCTURES INVOLVED	IPSILATERAL FINDINGS	CONTRALATERAL FINDINGS
Medial Pontine (Foville)	Paramedian branches of basilar artery	Corticospinal tract, medial lemniscus, CN VI nucleus/fascicle, CN VII fascicle, PPRF	CN VI palsy (lateral rectus), LMN CN VII palsy, conjugate gaze palsy toward lesion side	Hemiparesis, loss of proprioception and vibration
Millard-Gubler	Paramedian branches (ventral caudal pons)	Corticospinal tract, CN VI fascicle, CN VII fascicle	CN VI palsy, LMN CN VII palsy	Hemiparesis (face spared on contralateral side)
Raymond	Paramedian branches (ventral pons)	Corticospinal tract, CN VI fascicle	CN VI palsy only	Hemiparesis
Lateral Pontine (Marie-Foix)	AICA or long circumferential branches	Spinothalamic tract, CN V spinal nucleus, CN VII nucleus, CN VIII, middle cerebellar peduncle, sympathetic fibers	LMN CN VII palsy, sensorineural hearing loss, vertigo/nystagmus, cerebellar ataxia, facial numbness (pain/temp), Horner syndrome	Loss of pain and temperature in body
Locked-in Syndrome	Bilateral basilar artery (ventral pons)	Bilateral corticospinal tracts, bilateral corticobulbar tracts	Quadriplegia, bilateral facial palsy, anarthria; consciousness and vertical eye movements preserved	(Bilateral involvement)
One-and-a-Half Syndrome	Paramedian branches or demyelination	Ipsilateral PPRF (or CN VI nucleus) + ipsilateral MLF	Conjugate gaze palsy toward lesion (the "one") + impaired adduction when looking away from lesion (the "half"); only remaining horizontal movement is abduction of the contralateral eye	Nystagmus in the abducting contralateral eye

The one-and-a-half syndrome deserves additional emphasis. When both the PPRF and the MLF on the same side are damaged, the patient loses all horizontal gaze toward the lesion (the "one," a full conjugate gaze palsy) and also loses adduction of the ipsilateral eye when attempting to look away from the lesion (the "half," an internuclear ophthalmoplegia). The net result is that the only horizontal eye movement remaining is abduction of the contralateral eye. In a young patient, the most likely cause is multiple sclerosis. In an older patient, consider ischemic stroke.

3. Diagnostic Workup

TEST	ROLE	KEY FINDINGS
Non-contrast CT of the head	Best initial test (to rule out hemorrhage)	Often negative for acute ischemic pontine stroke due to bone artifact in posterior fossa; will show hemorrhage if present
MRI brain with DWI	Most accurate test / gold standard for posterior fossa ischemia	Restricted diffusion in the pons on DWI with corresponding dark signal on ADC map; precisely localizes the infarct
MRA or CTA	Vascular assessment	Stenosis, occlusion, or dissection of the basilar artery or vertebral arteries
Conventional angiography (DSA)	Gold standard for vascular anatomy (rarely needed acutely)	Defines exact vessel pathology; used when endovascular intervention is planned
ECG and telemetry	Identify cardioembolic source	Atrial fibrillation, other arrhythmias
Echocardiography (TTE/TEE)	Identify cardioembolic source	Valvular disease, intracardiac thrombus, patent foramen ovale
Routine labs	Baseline and risk stratification	CBC, BMP, coagulation studies, lipid panel, $HbA_{1c}$, ESR

The first step in any suspected stroke is a non-contrast CT head to differentiate ischemic from hemorrhagic stroke, because this distinction determines whether thrombolysis is appropriate. However, CT is notoriously poor at detecting acute ischemic infarcts in the posterior fossa. The brainstem is surrounded by dense petrous bone, which creates significant artifact. A normal CT does not rule out a pontine stroke.

The gold standard for diagnosing pontine infarction is MRI with diffusion-weighted imaging. DWI detects cytotoxic edema within minutes of ischemia onset, appearing as a bright signal in the affected territory. The corresponding ADC (apparent diffusion coefficient) map shows a dark signal, confirming true restricted diffusion rather than T2 shine-through. MRI also allows precise anatomical localization within the pons, which correlates directly with the clinical syndrome (medial versus lateral, rostral versus caudal).

Vascular imaging with CTA or MRA should be obtained to evaluate the basilar and vertebral arteries. Basilar artery occlusion is a neurological emergency with high mortality and requires urgent consideration for endovascular thrombectomy. In cases where the diagnosis is unclear or intervention is planned, digital subtraction angiography (DSA) provides the most detailed vascular map.

A cardiac workup including ECG, continuous telemetry, and echocardiography is essential to identify cardioembolic sources. For patients under 60 with cryptogenic stroke, a TEE with bubble study should be considered to evaluate for patent foramen ovale.

4. Management and Treatment

PHASE	INTERVENTION	DETAILS
Hyperacute (0 to 4.5 hours)	IV alteplase	0.9 mg/kg (max 90 mg); 10% as bolus over 1 minute, remaining 90% infused over 60 minutes
Hyperacute (large vessel occlusion)	Endovascular thrombectomy	For basilar artery occlusion; can be considered up to 24 hours from symptom onset in select patients based on perfusion imaging
Acute supportive	Blood pressure management	Permissive hypertension (allow up to 220/120 mmHg if no thrombolysis); if alteplase given, keep below 180/105 mmHg for 24 hours
Acute supportive	Airway and swallow assessment	Pontine strokes carry high aspiration risk due to bulbar dysfunction; early speech-language pathology evaluation
Secondary prevention (antiplatelet)	Aspirin or aspirin + clopidogrel	Aspirin 160 to 325 mg daily; dual antiplatelet (aspirin 81 mg + clopidogrel 75 mg) for 21 days in minor stroke, then transition to monotherapy
Secondary prevention (anticoagulation)	Warfarin or DOAC	For cardioembolic etiology (e.g., atrial fibrillation); warfarin with INR target 2.0 to 3.0, or apixaban 5 mg twice daily, rivaroxaban 20 mg daily, or dabigatran 150 mg twice daily
Long-term risk factor control	Statin, antihypertensive, glycemic control	High-intensity statin (atorvastatin 40 to 80 mg or rosuvastatin 20 to 40 mg); target BP below 130/80 mmHg; $HbA_{1c}$ below 7%
Locked-in syndrome	Supportive and rehabilitative care	Tracheostomy, PEG tube feeding, communication devices (eye-tracking technology), DVT prophylaxis, physical therapy

In the hyperacute phase, the priority is determining eligibility for IV alteplase. The same inclusion and exclusion criteria apply as for any ischemic stroke: symptom onset within 4.5 hours, no evidence of hemorrhage on CT, no recent surgery or active bleeding, platelets above 100,000, and INR below 1.7. Alteplase is dosed at 0.9 mg/kg with a maximum of 90 mg; 10% is given as an IV bolus, and the remainder infuses over 60 minutes. Blood pressure must be maintained below 180/105 mmHg for 24 hours following thrombolysis.

Basilar artery occlusion is treated as a large-vessel occlusion emergency. Endovascular mechanical thrombectomy is strongly considered because basilar occlusion carries an extremely high mortality rate without recanalization. Evidence supports thrombectomy for basilar occlusion with an extended window of up to 24 hours in appropriately selected patients, which is notably longer than for anterior circulation large-vessel occlusions.

Antiplatelet therapy with aspirin is started 24 hours after alteplase administration. For minor non-cardioembolic strokes, dual antiplatelet therapy (aspirin 81 mg plus clopidogrel 75 mg daily) is given for 21 days, then the patient is transitioned to single-agent therapy. If the etiology is cardioembolic, anticoagulation replaces antiplatelet therapy; direct oral anticoagulants are preferred over warfarin for non-valvular atrial fibrillation. Anticoagulation is typically initiated 3 to 14 days after the infarct, depending on stroke size and hemorrhagic transformation risk.

For locked-in syndrome, there is no treatment that restores motor function. Management is entirely supportive: securing the airway (often requiring tracheostomy), nutritional support via percutaneous gastrostomy, DVT prophylaxis with subcutaneous heparin or pneumatic compression devices, and early initiation of communication aids such as eye-tracking systems. Despite the devastating motor deficit, cognitive rehabilitation and psychological support are critical because these patients are fully aware.

5. Differential Diagnosis and Distractors

DIFFERENTIAL	WHY IT IS SIMILAR	KEY DISCRIMINATOR
Lateral medullary syndrome (Wallenberg)	Crossed sensory findings, vertigo, nystagmus, Horner syndrome, ipsilateral cerebellar ataxia	Wallenberg involves CN IX/X (dysphagia, hoarseness, absent gag reflex) and does NOT cause hearing loss or facial motor weakness; supplied by PICA, not AICA
Weber syndrome (midbrain)	Crossed hemiparesis with ipsilateral cranial nerve palsy	Weber involves CN III (ptosis, "down and out" eye, dilated pupil), not CN VI or VII; lesion is in the midbrain, not the pons
Cerebellar stroke	Vertigo, nystagmus, ataxia, headache, vomiting	Pure cerebellar stroke lacks cranial nerve palsies and long-tract signs (no hemiparesis, no crossed sensory deficits)
Basilar migraine (migraine with brainstem aura)	Vertigo, diplopia, dysarthria, bilateral sensory changes, altered consciousness	Fully reversible symptoms; normal MRI; episodic history; headache follows the aura; no permanent cranial nerve deficits
Brainstem glioma	Progressive cranial nerve palsies, long-tract signs, ataxia	Subacute or chronic progressive course (weeks to months) rather than sudden onset; enhancing mass on MRI; most common in children
Myasthenia gravis	Diplopia, ptosis, facial weakness, bulbar symptoms	Fluctuating weakness that worsens with fatigue; no sensory deficits; no hyperreflexia; positive anti-AChR antibodies; abnormal repetitive nerve stimulation
Persistent vegetative state	Appears similar to locked-in on superficial assessment	Vegetative state lacks awareness and purposeful responses; locked-in patients are fully conscious and can communicate with eye movements; EEG in locked-in shows normal awake patterns

The most commonly tested differential is distinguishing lateral pontine (AICA) syndrome from lateral medullary (Wallenberg/PICA) syndrome. Both produce vertigo, nystagmus, ipsilateral Horner syndrome, ipsilateral cerebellar ataxia, and crossed sensory findings. The discriminator is hearing loss and facial motor palsy: AICA syndrome causes ipsilateral sensorineural hearing loss (CN VIII) and ipsilateral LMN facial palsy (CN VII), while Wallenberg syndrome does not. Instead, Wallenberg syndrome produces dysphagia and hoarseness (CN IX/X), which are absent in AICA syndrome.

Another critical discrimination is between locked-in syndrome and a vegetative state. These are tested because they appear superficially identical at the bedside: neither patient speaks or moves voluntarily. The key is that the locked-in patient has preserved consciousness, intact cognition, and normal EEG patterns and can communicate via vertical eye movements and blinking. A vegetative-state patient has sleep-wake cycles but no purposeful awareness and no reproducible communication.

6. Traps and High-Yield Pearls

The most common trap in questions about pontine syndromes is confusing the gaze deviation pattern. In a cortical (hemispheric) stroke, the eyes deviate toward the lesion and away from the hemiparesis ("the eyes look at the lesion"). In a pontine stroke, the PPRF is destroyed, so the eyes deviate away from the lesion and toward the hemiparesis ("the eyes look at the paralyzed side"). If a vignette describes a patient with right hemiparesis and eyes deviating to the right, the lesion is in the pons, not the cortex. This is one of the most reliable localizing features tested.

A second trap is failing to recognize locked-in syndrome as a state of preserved consciousness. Vignettes may describe a patient who appears unresponsive following a basilar artery stroke but whose family reports that "she seems to follow us with her eyes." The wrong answer is persistent vegetative state or brain death. The right answer requires recognizing that bilateral ventral pontine destruction spares the reticular activating system and vertical gaze pathways.

A third common error is ordering CT instead of MRI for a posterior fossa stroke. When the vignette gives a classic brainstem syndrome with a normal CT, the next step is MRI with DWI, not repeating the CT or assuming the diagnosis is wrong. CT has poor sensitivity for posterior fossa ischemia, and this fact is tested repeatedly.

Finally, remember that one-and-a-half syndrome in a young patient should prompt evaluation for multiple sclerosis, not just stroke. If the vignette describes a young woman with episodic neurological deficits separated in time and space, with a pontine demyelinating lesion on MRI, the underlying diagnosis being tested is MS rather than vascular disease.

The core competency being assessed in pontine syndrome questions is the ability to localize a neurological lesion to the brainstem by recognizing crossed findings, then to pinpoint the lesion within the pons by identifying which cranial nerves and long tracts are involved, and finally to match the clinical pattern to the correct vascular territory.

1f:["$","$L2e",null,{"article":{"id":"6fd9f184-29c8-4678-a94b-41daccc00f2f","title":"Sindrom Pons/ Pontine Syndrome","content":"$2f","category":"Neurologi","created_at":"2026-09-03T17:00:37.150203+00:00","status":"published","subcategory":null},"questionCount":0,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]